메뉴 건너뛰기




Volumn 28, Issue 8, 2008, Pages 1117-1123

Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization

Author keywords

Antiangiogenic drugs; CNV; Lucentis; Myopia; Photodynamic therapy; Ranibizumab; Verteporphin

Indexed keywords

OFLOXACIN; RANIBIZUMAB; MONOCLONAL ANTIBODY;

EID: 58149268003     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31817eda41     Document Type: Article
Times cited : (76)

References (18)
  • 2
    • 0020575945 scopus 로고
    • Visual prognosis of disciform degeneration in myopia
    • Hampton GR, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983;90:923-926.
    • (1983) Ophthalmology , vol.90 , pp. 923-926
    • Hampton, G.R.1    Kohen, D.2    Bird, A.C.3
  • 3
    • 0033507014 scopus 로고    scopus 로고
    • Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization
    • Tabandeh H, Flynn HW Jr, Scott IU, et al. Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 1999;106:2063-2067.
    • (1999) Ophthalmology , vol.106 , pp. 2063-2067
    • Tabandeh, H.1    Flynn Jr, H.W.2    Scott, I.U.3
  • 4
    • 0036209618 scopus 로고    scopus 로고
    • Long-term visual prognosis of choroidal neovascularization in high myopia: A comparison between age groups
    • Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 2002;109: 712-719.
    • (2002) Ophthalmology , vol.109 , pp. 712-719
    • Yoshida, T.1    Ohno-Matsui, K.2    Ohtake, Y.3
  • 5
    • 0035038772 scopus 로고    scopus 로고
    • Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial - VIP report no. 1
    • Verteporfin in Photodynamic Therapy Study Group
    • Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-852.
    • (2001) Ophthalmology , vol.108 , pp. 841-852
  • 6
    • 0242500327 scopus 로고    scopus 로고
    • Verteporfin therapy of subfoveal choroidal neovascularisation in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no. 3
    • Verteporfin in Photodynamic Therapy (VIP) Study Group
    • Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularisation in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no. 3. Ophthalmology 2003;110:667-673.
    • (2003) Ophthalmology , vol.110 , pp. 667-673
  • 7
    • 0037309939 scopus 로고    scopus 로고
    • Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation
    • Montero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003;87:173-176.
    • (2003) Br J Ophthalmol , vol.87 , pp. 173-176
    • Montero, J.A.1    Ruiz-Moreno, J.M.2
  • 8
    • 33745782355 scopus 로고    scopus 로고
    • Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
    • Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2006;26:495-511.
    • (2006) Retina , vol.26 , pp. 495-511
    • Rich, R.M.1    Rosenfeld, P.J.2    Puliafito, C.A.3
  • 9
    • 35348944795 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) as primary treatment for myopic cho-roidal neovascularization
    • Mandal S, Venkatesh P, Sampangi R, Garg S. Intravitreal bevacizumab (Avastin) as primary treatment for myopic cho-roidal neovascularization. Eur J Ophthalmol 2007;17:620-626.
    • (2007) Eur J Ophthalmol , vol.17 , pp. 620-626
    • Mandal, S.1    Venkatesh, P.2    Sampangi, R.3    Garg, S.4
  • 10
    • 34447324654 scopus 로고    scopus 로고
    • Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia
    • Hernandez-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, et al. Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina 2007;27:707-712.
    • (2007) Retina , vol.27 , pp. 707-712
    • Hernandez-Rojas, M.L.1    Quiroz-Mercado, H.2    Dalma-Weiszhausz, J.3
  • 11
    • 67749085482 scopus 로고    scopus 로고
    • Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, et al. Intravit-reous bevacizumab to treat subfoveal choroidal neovascular-ization in highly myopic eyes: short-term results. Eye 2007. [epub ahead of print].
    • Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, et al. Intravit-reous bevacizumab to treat subfoveal choroidal neovascular-ization in highly myopic eyes: short-term results. Eye 2007. [epub ahead of print].
  • 12
    • 33846828813 scopus 로고    scopus 로고
    • Intravitreal Avastin for choroidal neovascularisation in pathological myopia: The controversy continues
    • Rosenfeld PJ. Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues. Br J Ophthalmol 2007;91:128-130.
    • (2007) Br J Ophthalmol , vol.91 , pp. 128-130
    • Rosenfeld, P.J.1
  • 13
    • 33846783133 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
    • Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol 2007;91:157-160.
    • (2007) Br J Ophthalmol , vol.91 , pp. 157-160
    • Yamamoto, I.1    Rogers, A.H.2    Reichel, E.3    Yates, P.A.4    Duker, J.S.5
  • 14
    • 33846785427 scopus 로고    scopus 로고
    • Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia
    • Sakaguchi H, Ikuno Y, Gomi F, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 2007;91: 161-165.
    • (2007) Br J Ophthalmol , vol.91 , pp. 161-165
    • Sakaguchi, H.1    Ikuno, Y.2    Gomi, F.3
  • 15
    • 36549066793 scopus 로고    scopus 로고
    • Intravitreal bevaci-zumab (Avastin) for myopic choroidal neovascularization. Six-month results of a prospective pilot study
    • Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevaci-zumab (Avastin) for myopic choroidal neovascularization. Six-month results of a prospective pilot study. Ophthalmology 2007;114:2190-2196.
    • (2007) Ophthalmology , vol.114 , pp. 2190-2196
    • Chan, W.M.1    Lai, T.Y.2    Liu, D.T.3    Lam, D.S.4
  • 16
    • 33749451356 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
    • (2006) N Engl J Med , vol.355 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 17
    • 33144456714 scopus 로고    scopus 로고
    • Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization
    • Tong JP, Chan WN, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006;141:456 -462.
    • (2006) Am J Ophthalmol , vol.141 , pp. 456-462
    • Tong, J.P.1    Chan, W.N.2    Liu, D.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.